Seer, Inc. (NasdaqGS: SEER)
Health Care · Life Sciences Tools & Services · US
$2.16
-1.37% today · -0.9% 1Y
Seer, Inc. (NasdaqGS: SEER) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $121.26M and employs 124 people.
Over the last twelve months the share price has lost 0.9%, trading between 1.55 and 2.41.
Tweenvest scores Seer, Inc. across four factors: quality 41/100, value 62/100, growth 76/100. Its strongest factor is growth.
SEER price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $121.26M
- Revenue (TTM)
- $14.22M
- P/E
- —
- EPS
- -1.22
- Dividend yield
- —
- Beta (5Y)
- 1.47
- 52-week high
- $2.41
- 52-week low
- $1.55
- Avg volume (3M)
- —
- Shares outstanding
- 55.37M
- Employees
- 124
- Next earnings
- —
About Seer, Inc.
Seer, Inc. is a life sciences firm specializing in developing and commercializing advanced technologies designed to unravel the complexities of the proteome. At the core of its offerings is the Proteograph Product Suite, an integrated platform comprising specialized consumables, automated instrumentation, and sophisticated software. This comprehensive solution empowers researchers to conduct advanced proteomic studies across various applications, including therapeutic and diagnostic investigations, as well as clinical trials. The company markets its products exclusively for research applications, serving academic institutions, diverse life sciences and research laboratories, and biopharmaceutical and biotechnology enterprises. Notably, these offerings are intended for non-diagnostic and non-clinical purposes. Seer has established collaborative agreements with entities such as Discovery Life Sciences, LLC, and the Salk Institute for Biological Studies. Originally incorporated in 2017 as Seer Biosciences, Inc., the company adopted its current name, Seer, Inc., in July 2018. Its headquarters are situated in Redwood City, California.
- ISIN
- US81578P1066
- Founded
- 2017
- Listed since
- Dec 4, 2020
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Codexis, Inc.NasdaqGS: CDXS | $154.40M | $1.33 | -6.03% |
| FutureChem Co.,LtdKOSDAQ: A220100 | $140.90M | ₩7,040.00 | -2.09% |
| Genovis AB (publ.)OM: GENO | $136.95M | Skr20.65 | +1.72% |
| NanoEntek, Inc.KOSDAQ: A039860 | $126.25M | ₩4,485.00 | -1.54% |
| Curiosis, Inc.KOSDAQ: A494120 | $109.53M | ₩9,650.00 | -1.03% |
| MaxCyte, Inc.NasdaqGS: MXCT | $104.24M | $0.98 | -2.85% |
| Eurofins-Cerep SAENXTPA: ALECR | $102.22M | €18,100.00 | +19.87% |
| Selvita S.A.WSE: SLV | $99.32M | zł21.00 | -0.94% |
Figures last refreshed Oct 11, 2026.